Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of vasculature development. [GOC:TermGenie]
Vasculature development, the intricate process of forming and organizing blood vessels, is tightly regulated by a complex interplay of signaling pathways, transcription factors, and extracellular matrix components. This finely tuned orchestration ensures proper blood supply to all tissues and organs, critical for their survival and function.
The initial step in vasculature development, known as vasculogenesis, involves the formation of blood vessels from angioblasts, specialized precursor cells. These angioblasts differentiate into endothelial cells, which line the inner surface of blood vessels. Simultaneously, vascular smooth muscle cells, which surround the endothelial cells, arise from mesenchymal progenitors.
Subsequent to vasculogenesis, angiogenesis, the sprouting of new blood vessels from pre-existing ones, takes place. This process is crucial for tissue growth, wound healing, and maintaining adequate blood flow. Angiogenesis involves a series of coordinated steps, including:
- **Activation of endothelial cells:** Growth factors, like vascular endothelial growth factor (VEGF), bind to their receptors on endothelial cells, triggering a cascade of intracellular signaling events.
- **Migration and proliferation of endothelial cells:** Activated endothelial cells migrate towards the source of the growth factor, proliferate, and form tubular structures called sprouts.
- **Sprout elongation and lumen formation:** The sprouts elongate and connect to neighboring vessels, forming new capillary loops. These newly formed vessels are then stabilized by the recruitment and differentiation of pericytes and smooth muscle cells, which contribute to vascular maturation and function.
The regulation of vasculature development involves a diverse array of signaling pathways, including:
- **VEGF signaling:** VEGF is the primary regulator of angiogenesis and acts through its receptors, VEGFR1 and VEGFR2, on endothelial cells. VEGF signaling activates multiple intracellular pathways, including the MAPK/ERK, PI3K/Akt, and Src pathways, leading to endothelial cell proliferation, migration, and survival.
- **Notch signaling:** Notch signaling plays a crucial role in vessel branching, lumen formation, and the maintenance of vascular integrity. Activation of the Notch receptor on endothelial cells leads to the expression of downstream target genes, regulating endothelial cell fate and behavior.
- **Wnt signaling:** Wnt signaling influences the development of both endothelial cells and vascular smooth muscle cells. It regulates cell proliferation, migration, and differentiation, contributing to the proper formation and organization of blood vessels.
- **TGF-β signaling:** TGF-β signaling is involved in the regulation of vascular permeability, endothelial cell survival, and the formation of vascular smooth muscle cells. It also plays a role in the process of angiogenesis, promoting both sprouting and stabilization of new blood vessels.
In addition to signaling pathways, transcription factors, such as KLF2, GATA2, and ETS1, play essential roles in regulating gene expression during vasculature development. These transcription factors control the expression of genes involved in endothelial cell differentiation, migration, and proliferation, ensuring proper vascular morphogenesis.
The extracellular matrix, composed of proteins and polysaccharides, provides structural support and guidance cues for blood vessel formation. Proteins like collagen, laminin, and fibronectin, which make up the extracellular matrix, interact with endothelial cells, promoting their adhesion, migration, and differentiation.
Dysregulation of vasculature development can lead to a range of diseases, including cardiovascular diseases, cancer, and developmental abnormalities. Understanding the complex mechanisms that regulate vascular development is crucial for developing therapeutic strategies to treat these diseases.
'"
Protein | Definition | Taxonomy |
---|---|---|
Disintegrin and metalloproteinase domain-containing protein 10 | A disintegrin and metalloproteinase domain-containing protein 10 that is encoded in the genome of human. [PRO:WCB, UniProtKB:O14672] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ilomastat | CS 610: matrix metalloproteinase inhibitor; structure in first source ilomastat : An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor | hydroxamic acid; L-tryptophan derivative; N-acyl-amino acid | anti-inflammatory agent; antibacterial agent; antineoplastic agent; EC 3.4.24.24 (gelatinase A) inhibitor; neuroprotective agent |
bms-566394 | BMS-566394: structure in first source | ||
incb3619 | INCB3619: ADAM inhibitor; structure in first source | ||
grassystatin a | grassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source |